Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade

Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade

The pretreatment serum albumin/globulin ratio (AGR) has been used as a prognostic biomarker for various cancer types. However, the prognostic value of the AGR for prostate cancer, especially for metastatic prostate cancer (mPCa) after maximal androgen blockade (MAB), remains unclear. The aim of this...

Full description

Bibliographic Details
Main Authors: Ning Wang, Jian-Ye Liu, Xiong Li, Min-Hua Deng, Zhi Long, Jin Tang, Kun Yao, Yi-Chuan Zhang, Le-Ye He
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Asian Journal of Andrology
Subjects:
albumin/globulin ratio; maximal androgen blockade; metastatic prostate cancer; prognosis; survival
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=56;epage=61;aulast=Wang

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=56;epage=61;aulast=Wang

Similar Items